Farzin Ali, Etesami Seyed Alireza, Quint Jacob, Memic Adnan, Tamayol Ali
Division of Engineering in Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02139, USA.
Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Adv Healthc Mater. 2020 May;9(9):e1901058. doi: 10.1002/adhm.201901058. Epub 2020 Mar 20.
There is urgency for the development of nanomaterials that can meet emerging biomedical needs. Magnetic nanoparticles (MNPs) offer high magnetic moments and surface-area-to-volume ratios that make them attractive for hyperthermia therapy of cancer and targeted drug delivery. Additionally, they can function as contrast agents for magnetic resonance imaging (MRI) and can improve the sensitivity of biosensors and diagnostic tools. Recent advancements in nanotechnology have resulted in the realization of the next generation of MNPs suitable for these and other biomedical applications. This review discusses methods utilized for the fabrication and engineering of MNPs. Recent progress in the use of MNPs for hyperthermia therapy, controlling drug release, MRI, and biosensing is also critically reviewed. Finally, challenges in the field and potential opportunities for the use of MNPs toward improving their properties are discussed.
Adv Healthc Mater. 2020-5
Recent Pat Drug Deliv Formul. 2017
Nanotechnology. 2019-9-6
J Biomed Mater Res A. 2016-5
Adv Colloid Interface Sci. 2019-1-23
J Nanosci Nanotechnol. 2015-1
J Biomed Nanotechnol. 2014-1
Biosensors (Basel). 2022-9-25
Front Drug Deliv. 2025-7-30
Pharmaceutics. 2025-6-24
Mater Today Bio. 2025-5-26
Pharmaceutics. 2025-5-16
Adv Healthc Mater. 2019-8-12
Adv Colloid Interface Sci. 2019-7
Nat Biomed Eng. 2017-8
Adv Healthc Mater. 2019-4-15
Int J Nanomedicine. 2019-3-11